INNT
TOTAL INVALIDATION PROCESSED BY THE IB
09/03/2023
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Mark description
The mark consists of a miscellaneous design on the left, four Chinese characters on the right and the words "LUYE PHARMA" on the top of the Chinese characters.
Holders
Representatives
MATTHEW D. ASBELL LADAS & PARRY LLP
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposes and drugs for medical purposes namely, sodium aescinate injections for the treatment of cerebral edema and edema caused by trauma or operations and of venous back flow obstruction diseases, sodium glycididazole injections in the nature of radiosensitizer for the radiotherapy of solid tumors such as head and neck tumor, lung cancer, and esophageal cancer, and reduced glutathione injections for the treatment of alcoholic fatty liver, alcoholic liver fibrosis, alcoholic liver cirrhosis, acute alcoholic hepatitis, poisoning by radiotherapy, drugs and chemicals; medicinal drinks; pharmaceutical preparations, chemico-pharmaceutical preparations, and chemical preparations for pharmaceutical purposes, namely, sodium aescinate tablets for the treatment of venous edema and soft tissue swelling due to various causes, smectite dispersible tablets and smectite powder sachets for the treatment of acute and chronic bacillary diarrhea of adults and children and for the treatment of pains caused by gullet, stomach and duodenum diseases but not used for spasmolysant, and elcatonin injections for the treatment of bone pains caused by osteoporesis, of hypercalaemia, and of scleromalacia; biological preparations for medical purposes; tonics being medicines, namely, largetrifoliolious bugbane rhizome tablets for the treatment of the pre-menopausal, menopausal and post menopausal syndrome of women, used to relieve the symptoms of hot sweating, restlessness, insomnia, flank pain, dizziness, and tinnitus; gelatin for medical purposes, namely, compound sodium aescinate gel used to relieve the swelling caused by inflammation, degenerative diseases, wounds, ridge pains such as spondylalgia, lumbago, rachialgia, sciatica, closed type acute tissue injuries, lesion in the inter-vertebral disks, varicose of veins, and peritonitis and phlebitis, capsaicin gel used to relieve arthritis and/or muscle pains caused by osteoarthritis, rheumatoid arthritis, myelitis, and fibromyalgia pains caused by sprains to joints; capsules for pharmaceutical purposes, namely, pantoprazole pellets capsules for the treatment of duodenal ulcer, gastric ulcer and acute pathological changes of gastric mucosa, reflux esophagitis and Zollinger-Ellison Syndrome
History of USPTO decisions and trademark events.
59 publications found
TOTAL INVALIDATION PROCESSED BY THE IB
09/03/2023
GENERIC MADRID TRANSACTION SENT TO IB
07/27/2023
GENERIC MADRID TRANSACTION CREATED
07/27/2023
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/11/2023
CANCELLED SECTION 71
11/11/2022
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/24/2021
INTERNATIONAL REGISTRATION RENEWED
11/28/2019
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/12/2019
REGISTERED-SEC.71 ACCEPTED
08/12/2019
NEW REPRESENTATIVE AT IB RECEIVED
06/21/2019
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/14/2019
POST REGISTRATION ACTION MAILED - SEC.71
01/18/2019
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/15/2018
TEAS SECTION 71 RECEIVED
10/18/2018
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/15/2016
NOTIFICATION PROCESSED BY IB
11/14/2012
FINAL DECISION TRANSACTION PROCESSED BY IB
08/29/2012
FINAL DISPOSITION NOTICE SENT TO IB
08/03/2012
FINAL DISPOSITION PROCESSED
08/02/2012
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/24/2012
REGISTERED-PRINCIPAL REGISTER
04/24/2012
NOTIFICATION PROCESSED BY IB
02/11/2012
PUBLISHED FOR OPPOSITION
02/07/2012
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/18/2012
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/18/2012
NOTICE OF PUBLICATION
01/18/2012
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/04/2012
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2012
TEAS/EMAIL CORRESPONDENCE ENTERED
12/29/2011
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/29/2011
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/29/2011
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/21/2011
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/21/2011
NON-FINAL ACTION MAILED
08/09/2011
NON-FINAL ACTION WRITTEN
08/08/2011
TEAS/EMAIL CORRESPONDENCE ENTERED
07/19/2011
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/19/2011
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/19/2011
NON-FINAL ACTION MAILED
04/26/2011
NON-FINAL ACTION WRITTEN
04/26/2011
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2011
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2011
ASSIGNED TO LIE
03/07/2011
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/23/2011
NON-FINAL ACTION MAILED
10/07/2010
NON-FINAL ACTION WRITTEN
10/07/2010
TEAS/EMAIL CORRESPONDENCE ENTERED
09/17/2010
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2010
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/17/2010
REFUSAL PROCESSED BY IB
06/04/2010
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/27/2010
REFUSAL PROCESSED BY MPU
04/27/2010
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/27/2010
NON-FINAL ACTION WRITTEN
04/26/2010
APPLICATION FILING RECEIPT MAILED
04/23/2010
ASSIGNED TO EXAMINER
04/19/2010
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/19/2010
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
04/16/2010
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/15/2010
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.